FDA-Approved Botox Brands 2026: 6 Legal Neurotoxins and the Turkey Market

Patients often use the word Botox as if every botulinum toxin product were interchangeable. In reality, brand identity matters because formulation, unit system, diffusion profile, storage requirements and regulatory status are not the same.

As of 2026, the FDA has cleared six aesthetic neurotoxin brands for cosmetic use: Botox Cosmetic, Dysport, Xeomin, Jeuveau, Daxxify and Letybo. Outside that list, a clinic should be able to explain exactly what product is being used and whether it is legally imported into Turkey.

1. FDA, TİTCK and CE do not mean the same thing

FDA approval is the strongest public reference point for cosmetic neurotoxins because it requires large phase III trials and long-term safety review. TİTCK is the Turkish regulator that evaluates whether a product can legally enter the domestic pharmaceutical system.

A CE mark alone is not enough reassurance for a botulinum toxin vial. These products sit in the medicine category, so clinics should be able to show a legitimate regulatory file and a traceable pharmaceutical supply chain.

• FDA: cosmetic efficacy and safety benchmark
• TİTCK: legal import and traceability in Turkey
• CE alone: not sufficient for injectable neurotoxins

2. The six FDA-cleared aesthetic brands

Botox Cosmetic (onabotulinumtoxinA) remains the most documented option and the reference point for many comparative studies. Dysport (abobotulinumtoxinA) is often chosen when a slightly faster onset or broader spread is useful. Xeomin (incobotulinumtoxinA) removes accessory complexing proteins and can be attractive for long-term toxin users.

Jeuveau (prabotulinumtoxinA) is an aesthetic-only brand in the US market. Daxxify (daxibotulinumtoxinA) is positioned around a longer duration, while Letybo (letibotulinumtoxinA) is the newest FDA-cleared entrant with narrower real-world experience so far.

• Botox / Vistabel: the classic benchmark
• Dysport / Azzalure: faster onset, broader diffusion
• Xeomin / Bocouture: purified core toxin without complexing proteins
• Jeuveau: aesthetic-only positioning
• Daxxify: longest duration claim
• Letybo: newest FDA-cleared entrant

3. What is legal in Turkey right now?

In daily practice, the key issue is not only whether a product exists globally, but whether it has legal Turkish market access and can be tracked through the official drug system. Botox, Dysport and Xeomin are established references in that context.

When a clinic advertises Jeuveau or unnamed "Korean Botox" in Turkey, that should trigger caution. If a product has no TİTCK route, patients should assume a grey-market or non-pharmacy supply risk until proven otherwise.

• ask to see the vial and lot number
• ask whether the product can be verified in the Turkish tracking system
• be cautious with vague answers such as "premium Korean product"

4. Brands that need extra caution

Meditoxin, Innotox, Nabota, Hutox, Botulax and other low-cost products are frequently promoted online. Marketing visibility does not equal legal status, and patients should not assume a Korean origin automatically makes a toxin unsafe or automatically legitimate.

The clinical risk is not only the molecule itself. Smuggled transport, broken cold chain, counterfeit labels and uncertain dilution history can all damage safety and consistency long before the injection happens.

• cheap price is not proof of value
• cold-chain failures can reduce predictability
• counterfeit or relabeled vials create direct safety risk

5. How to protect yourself before injection

Ask the injector to name the exact brand, show the unopened vial, and document the lot number. Patients should also request a receipt or record that identifies the product rather than a generic line such as "Botox treatment."

Brand choice still comes after physician quality. A highly experienced injector using a legitimate, traceable product matters far more than chasing internet hype around the newest or cheapest toxin.

• verify the brand before treatment starts
• prefer clinics that discuss units, diffusion and follow-up clearly
• choose the physician first, then the toxin brand together